Do you want to read an article? Please log in or register.
Diversified Segmental Defocus Optimization Lenses With and Without Atropine for Myopia Prevention: A Randomized Clinical Trial
Further Publications
Related content
Lenses
Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine
Br J Ophthalmol
Guemes-Villahoz N, Talavero González P, Porras-Ángel P, Bella-Gala R, Ruiz-Pomeda A, Martin-Garcia B, Hernandez-Garcia E, Gomez de Liaño N, Shah R, Garcia-Feijoo J, Gomez-de-Liaño R
doi: 10.1136/bjo-2024-326852
Blindness and Vision Impairment
Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial
JAMA Ophthalmol
Xu H, Chen M, Ye L, Shu Q, Peng Y, Liang X, Yu T, Ji Y, Li S, Shen Q, He J, Li L, Zhu J, Xu X
doi: 10.1001/jamaophthalmol.2025.2321
RECOMMENDED
Further Publications
Efficacy and Safety of Different Atropine Regimens for the Treatment of Myopia in Children: Three-Year Results of the MOSAIC Randomized Clinical Trial
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
JAMA Ophthalmol
Loughman J, Lingham G, Nkansah EK, Kobia-Acquah E, Flitcroft DI
doi: 10.1001/jamaophthalmol.2024.5703
Macular DiseasesRetinal Diseases
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial
JAMA Ophthalmol
Pieramici DJ, Awh CC, Chang M, Emanuelli A, Holekamp NM, Hu AY, Suñer IJ, Wykoff CC, Brittain C, Howard D, Quezada-Ruiz C, Santhanakrishnan A, Latkany P
doi: 10.1001/jamaophthalmol.2025.0001
Further Publications
3-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial
Br J Ophthalmol
Hansen N, Hvid-Hansen A, Møller F, Bek T, Larsen D, Jacobsen N, Kessel L
doi: 10.1136/bjo-2024-326918
Lenses
Efficacy of spectacle lenses for myopia control: a meta-analysis of randomised controlled trials
Br J Ophthalmol
D'Andrea L, Rinaldi M, Piscopo R, Iorio F, La Padula S, Maqsood S, Elalfy M, Melenzane A, Confalonieri F, Ozkan O, Utine CA, Costagliola C
doi: 10.1136/bjo-2025-327629
Further Publications
Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial
JAMA Ophthalmol
Cohen EJ, Troxel AB, Liu M, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Warner DB, Lu Y, Twi-Yeboah A, Lee TF, Kim J, Lopez-Jimenez C, Laury SC, Jeng BH, ZEDS Trial Research Group
doi: 10.1001/jamaophthalmol.2024.6114
Further Publications
Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study: A Randomized Clinical Trial
JAMA Ophthalmol
Warner DB, Jeng BH, Kim J, Liu M, Troxel AB, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Meyer JJ, Lu Y, Twi-Yeboah A, Lee TF, Lopez-Jimenez C, Laury SC, Cohen EJ, ZEDS Trial Research Group
doi: 10.1001/jamaophthalmol.2024.6113
Lenses
Effect of daily disposable Defocus Incorporated Soft Contact lens on myopia control: a 1-year multicentre randomised controlled trial
Br J Ophthalmol
Liu L, Wang J, Tse DY, Zuo B, Song D, Du B, Chen Z, To CH, Chun RKM, Jiang J, Wei R
doi: 10.1136/bjo-2025-327471